King & Spalding Strengthens Regulatory Practice with Addition of Former FDA Official

In a notable development within the legal and regulatory sectors, King & Spalding announced the addition of a former U.S. Food and Drug Administration (FDA) official to their government matters and regulation practice group. This new team member brings to the firm a wealth of experience from an extensive eight-year tenure at the FDA. The move is expected to enhance King & Spalding’s capabilities in life sciences regulation, a critical area as the intersection of law and healthcare continues to evolve. For more details, you can read the announcement on Law360.